Are High Procedure Costs Restricting Global Bone Marrow Transplant Market from Rising Steadily?

The prevalence of leukemia has been registering a rapid rise worldwide. According to the World Cancer Report by the WHO, in 2012, 352,000 people were diagnosed with leukemia across the world, causing a total of 265,000 deaths. Another report by The Cancer Research UK states that the recorded number of new leukemia cases in the U.K. in 2013 was 9,300. The National Cancer Institute notes that in the U.S. alone, a total of 52,380 new cases of leukemia were recorded in 2014.

In the recent times, bone marrow transplant has emerged as the most effective treatment for leukemia, thalassemia, and various other blood disorders such as severe anemia, Hodgkin’s lymphoma, and non-Hodgkin’s lymphoma.

A report, published by Transparency Market Research (TMR), states that the rising awareness regarding the efficiency of bone marrow transplant in the treatment of these diseases has boosted its popularity significantly across the world. In this blog post, analysts at TMR answer significant questions about the global bone marrow transplant market:

What are the primary drivers of the global bone marrow transplant market?

The rising incidence of leukemia is the key driver for the bone marrow transplant market, worldwide. The sedentary lifestyle of people, coupled with the high consumption of tobacco and alcohol, has triggered the prevalence of cancer, specifically leukemia over the past few years, resulting in the increasing demand for bone marrow transplants.

The infrastructural development in the healthcare industry required to carry out these transplants is also boosting the global market considerably.

What are the trends that are restricting the global bone marrow transplant market from reporting steady growth?

The most important factor that is restricting this market from registering a steady rise is the high cost associated with these transplants.

The process of bone marrow transplant is highly sophisticated and needs continuous monitoring and post-operative care, which makes it quite expensive for a middle-class patient. The lack of favorable reimbursement policies makes the situation even worse. Apart from this, the dearth of bone marrow donors, owing to the limited awareness regarding the procedure in emerging economies is also hampering the growth of the global bone marrow transplant market remarkably.

Browse Research Report: 

http://www.transparencymarketresearch.com/bone-marrow-transplant-market.html

What are the factors that are propelling the Europe bone marrow transplant market?

Europe has emerged as the leading bone marrow transplant market across the world. The presence of excellent public healthcare facilities and some of the major international market players has enabled this region to hold the largest share in the global market. Analysts project Europe to maintain its lead in the coming years.

STEMCELL Technologies, Lonza Group Ltd., AllCells, American Type Culture Collection (ATCC), Merck Millipore, and Sanofi-Aventis are the major enterprises functioning in the global bone marrow transplant market.